Definitive Contract 75D30120C09811

Award Date 9/28/20
Potential Completion Date 3/27/22
Potential Value $96K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30322, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University. The contract, valued at $630,506.00, is for services performed under the 2019 Broad Agency Announcement (BAA) and has a completion date of May 15, 2022. Emory University is a private research university that has an extensive track record of performing federally funded research and providing services to the government...
Emory University, operating as Emory University Office of Sponsored Programs Division, has been awarded a definitive contract by the Centers for Disease Control and Prevention (CDC) to perform work relating to determining antigenic drift with human monoclonal antibodies to hemagglutinin. Valued at approximately $901,182, this firm fixed price contract will be performed in Atlanta, Georgia over a two-year period concluding in September 2021. As part of its broader infectious disease programs, the...
This is a $245,000 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract, titled "EMORY-SARS COV2 CRYIEM," is for research and services related to the COVID-19 virus. The contract has an ultimate completion date of August 30, 2024. Emory University is a major recipient of federal contracts and grants, particularly in the areas of biomedical...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,000.00 firm fixed-price purchase order to Emory University's Office of Sponsored Programs Division for biologicals. The work will be performed in Atlanta, Georgia and have a completion date of June 30, 2023. The contract is not set aside for a designated socioeconomic group. Emory University is a private research university that has a history of providing clinical trial, data...
The federal contract award, ID 75D30123C16926, was granted to Emory University by the Centers for Disease Control and Prevention (CDC) for a Broad Agency Announcement (BAA) topic 33.1. The $1,807,738.00 Firm Fixed Price contract has a completion date of September 10, 2026. Emory University, a private research university in Atlanta, Georgia, will provide products and services under this contract through its Office of Sponsored Programs Division. The contract is not set aside for any specific...
This contract, awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, is for "BLOOD DRAW #2 COVID 19" services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $144,665.85. The period of performance ends on September 30, 2020. Emory University, a private research university located in Atlanta, Georgia, has an extensive track record of performing federally funded research and...
The federal contract award 75D30121C10084 was issued by the Centers for Disease Control and Prevention (CDC) to Emory University for "SARS - COV-2 APPLIED RESEARCH FOR NCEZID". The $622,108.90 firm-fixed price contract runs through November 28, 2022 and does not have a set-aside designation. Emory University, a private research university based in Atlanta, Georgia, has an extensive track record of performing federally funded research and providing services to the government. This...
This $571,955.88 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for serological testing services and does not have a set-aside designation. Emory University has an extensive track record of performing federally funded research and providing services to government agencies through contracts and grants, including in areas such as infectious disease...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract is for laboratory analysis services with a firm fixed price of $77,297.50 and a completion date of September 14, 2023. Emory University has an extensive track record of performing federally funded research and providing services to the government, including work for the CDC...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $144,702 firm-fixed-price purchase order to Emory University Office of Sponsored Programs for "LONG ARV" services. The order was placed on September 13, 2017, with a completion date of April 30, 2020. No set-aside designation was used. Emory University is a private university and non-profit organization that conducts public health research and programs for federal agencies, including...

Emory University Office of Sponsored Programs Division was awarded a $96,146 firm fixed price contract by the Centers for Disease Control and Prevention for support of the SARS COV-2 Broad Agency Announcement. No set-aside designation was applied. Work will be performed in Atlanta, Georgia through March 2022. This contract is likely associated with Emory University's previously awarded multiple award indefinite delivery contract from the CDC worth up to $86 million to provide clinical immunization safety assessment services from 2023 through 2028. Under the larger vehicle, Emory has received $1.98 million in delivery orders to date to support the CDC's immunization safety programs.

Generated 3/1/24, 10:38 AM